Lixte Biotechnology Holdings, Inc. (LIXTW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 190.24M |
| Enterprise Value | 185.8M |
| P/E Ratio | -6.73 |
| PEG Ratio | -0.27 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 10.43 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -11.75 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.67 |
| Return On Equity | -1.26 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -6M |
| Net Income | -6.01M |
| Diluted EPS | -1.26 |
| Total Cash | 3.25M |
| Total Cash/Share | 0.3 |
| Total Debt | 1.06M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 2.78 |
| Book Value Per Share | 0.84 |
| 52-Week Change | -26.33 |
| 52-Week High | 0.38 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.13 |
| Moving Average 200 Days | 0.11 |
| Average Volume | 24,045 |
| Shares Outstanding | 4.55M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |